Immunomodulation in cancer therapeutics
- 31 August 2003
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 3 (8) , 1105-1119
- https://doi.org/10.1016/s1567-5769(03)00021-3
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2JNCI Journal of the National Cancer Institute, 1994
- Effect of cancer therapy on host response and immunobiologyCurrent Opinion in Oncology, 1991
- Indomethacin modulation of Adriamycin-induced effects on multiple cytolytic effector functionsCancer Immunology, Immunotherapy, 1990
- Studies on the mechanism of activation of human natural killer function by interferon and inhibitors of thymidylate synthesisCellular Immunology, 1988
- Effects of Chemotherapeutic Agents on the Immune Response. IICancer Investigation, 1985
- Effects of Chemotherapeutic Agents on the Immune Response. ICancer Investigation, 1984
- Adriamycin induced immunomodulation: Dependence upon time of administrationInternational Journal of Immunopharmacology, 1983
- Selective Effects of Adriamycin on Murine Host Defense SystemsImmunological Reviews, 1982
- Modulation of the immune response by by chemotherapyPharmacology & Therapeutics, 1981
- Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea PigJournal of Investigative Dermatology, 1967